Largest health care companies by cash on hand
Cash and cash equivalents at the end of the latest fiscal year. Short-term investments are not counted.
UnitedHealth Group leads the 170 health care companies ranked by cash on hand, at SAR 91.4B, ahead of Johnson & Johnson (SAR 73.9B) and Centene (SAR 67.1B). Figures as of 20 Nov 2026, 11:43 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 170
- First
- UnitedHealth GroupSAR 91.4B
- Median
- SAR 2.2B
- Combined market value
- SAR 33.47T
- Countries
- 14
Market values as of .
All countries▾
Health Care▾
All categories▾
| # | Company | Cash on hand ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 101 | Merit Medical SystemsMMSI · Health Care | SAR 1.7B | SAR 19B | SAR 316.70 | 1.77% down | 1% up | ||
| 102 | STERISSTE · Health Care | SAR 1.6B | SAR 92.8B | SAR 955.83 | 1.85% down | 3% down | ||
| 103 | Quest DiagnosticsDGX · Health Care | SAR 1.6B | SAR 106.9B | SAR 972.08 | 0.23% down | 35% up | ||
| 104 | AlkermesALKS · Health Care | SAR 1.5B | SAR 29.1B | SAR 173.26 | 1.43% down | 66% up | ||
| 105 | Revolution MedicinesRVMD · Health Care | SAR 1.4B | SAR 129.4B | SAR 598.17 | 0.24% down | 129% up | ||
| 106 | Bausch + LombBLCO · Health Care | SAR 1.4B | SAR 27.8B | SAR 77.63 | 1.24% down | 37% up | ||
| 107 | TeleflexTFX · Health Care | SAR 1.4B | SAR 24.3B | SAR 613.06 | 1.48% down | 48% up | ||
| 108 | Guardant HealthGH · Health Care | SAR 1.4B | SAR 73.9B | SAR 546.24 | 0.31% up | 38% up | ||
| 109 | Ionis PharmaceuticalsIONS · Health Care | SAR 1.4B | SAR 17B | SAR 102.13 | 0.62% down | 64% down | ||
| 110 | AvantorAVTR · Health Care | SAR 1.4B | SAR 38.4B | SAR 56.73 | 1.63% down | 40% up | ||
| 111 | Lantheus HoldingsLNTH · Health Care | SAR 1.3B | SAR 25.1B | SAR 383.07 | 0.10% up | 83% up | ||
| 112 | Praxis Precision MedicinesPRAX · Health Care | SAR 1.3B | SAR 32.6B | SAR 1,166.47 | 1.87% up | 83% up | ||
| 113 | Kymera TherapeuticsKYMR · Health Care | SAR 1.3B | SAR 38.2B | SAR 447.94 | 1.44% down | 87% up | ||
| 114 | Belite BioBLTE · Health Care | SAR 1.3B | SAR 23B | SAR 566.61 | 3.33% down | 25% up | ||
| 115 | CRISPR TherapeuticsCRSP · Health Care | SAR 1.3B | SAR 14.2B | SAR 146.06 | 3.14% down | 22% down | ||
| 116 | Scholar Rock HoldingSRRK · Health Care | SAR 1.2B | SAR 23.1B | SAR 188.98 | 4.94% up | 26% up | ||
| 117 | Axsome TherapeuticsAXSM · Health Care | SAR 1.2B | SAR 26.8B | SAR 509.06 | 1.25% up | 9% down | ||
| 118 | HealthEquityHQY · Health Care | SAR 1.2B | SAR 30.2B | SAR 365.36 | 0.07% up | 4% down | ||
| 119 | Cogent BiosciencesCOGT · Health Care | SAR 1.2B | SAR 18.1B | SAR 104.08 | 0.25% down | 25% down | ||
| 120 | BrukerBRKR · Health Care | SAR 1.1B | SAR 35.6B | SAR 232.99 | 1.83% down | 44% up | ||
| 121 | MiniMed GroupMMED · Health Care | SAR 1.1B | SAR 17.2B | SAR 61.01 | 4.30% down | 8% down | ||
| 122 | Mirum PharmaceuticalsMIRM · Health Care | SAR 1.1B | SAR 23.4B | SAR 358.34 | 3.27% up | 34% up | ||
| 123 | Amneal PharmaceuticalsAMRX · Health Care | SAR 1.1B | SAR 28B | SAR 80.25 | 2.24% down | 90% up | ||
| 124 | Bio-TechneTECH · Health Care | SAR 993.2M | SAR 42.8B | SAR 272.76 | 0.07% down | 18% up | ||
| 125 | Definium TherapeuticsDFTX · Health Care | SAR 967.4M | SAR 15.1B | SAR 110.61 | 1.24% up | 168% up | ||
| 126 | GRAILGRAL · Health Care | SAR 937M | SAR 17.7B | SAR 393.35 | 2.68% up | 19% up | ||
| 127 | LifeStance Health GroupLFST · Health Care | SAR 932.9M | SAR 19B | SAR 50.05 | 3.12% down | 107% up | ||
| 128 | HaemoneticsHAE · Health Care | SAR 920.9M | SAR 20.6B | SAR 451.62 | 2.03% down | 53% up | ||
| 129 | Option Care HealthOPCH · Health Care | SAR 872.8M | SAR 17.8B | SAR 118.60 | 0.32% down | 7% up | ||
| 130 | Hims & Hers HealthHIMS · Health Care | SAR 857.7M | SAR 14.1B | SAR 60.11 | 6.04% down | 49% down | ||
| 131 | Arrowhead PharmaceuticalsARWR · Health Care | SAR 850M | SAR 23.2B | SAR 163.77 | 1.25% up | 13% up | ||
| 132 | Summit TherapeuticsSMMT · Health Care | SAR 845.2M | SAR 31.7B | SAR 39.66 | 0.67% up | 35% down | ||
| 133 | Charles River Laboratories InternationalCRL · Health Care | SAR 802M | SAR 59B | SAR 1,230.36 | 1.60% down | 96% up | ||
| 134 | Kodiak SciencesKOD · Health Care | SAR 787.4M | SAR 24B | SAR 367.31 | 0.09% up | 371% up | ||
| 135 | Madrigal PharmaceuticalsMDGL · Health Care | SAR 745.5M | SAR 34.6B | SAR 1,488.53 | 0.34% down | 28% down | ||
| 136 | PACS GroupPACS · Health Care | SAR 739.2M | SAR 25.6B | SAR 161.44 | 7.06% down | 77% up | ||
| 137 | PenumbraPEN · Health Care | SAR 701.2M | SAR 47.3B | SAR 1,200.65 | 0.18% down | 15% up | ||
| 138 | Twist BioscienceTWST · Health Care | SAR 686.8M | SAR 28.6B | SAR 418.79 | 4.07% down | 291% up | ||
| 139 | IDEXX LaboratoriesIDXX · Health Care | SAR 675.6M | SAR 203.9B | SAR 2,587.50 | 1.26% down | 1% up | ||
| 140 | Ligand PharmaceuticalsLGND · Health Care | SAR 656.3M | SAR 21.5B | SAR 1,076.57 | 3.94% down | 50% up | ||
| 141 | VaxcytePCVX · Health Care | SAR 652.7M | SAR 34.7B | SAR 218.96 | 0.27% down | 22% up | ||
| 142 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | SAR 621.3M | SAR 27.6B | SAR 350.93 | 1.59% down | 129% up | ||
| 143 | MSA SafetyMSA · Health Care | SAR 619.3M | SAR 25.5B | SAR 661.23 | 0.68% down | 16% up | ||
| 144 | Dr. Reddy's LaboratoriesRDY · Health Care | SAR 613.5M | SAR 46.4B | SAR 55.64 | 1.00% down | 7% up | ||
| 145 | Henry ScheinHSIC · Health Care | SAR 585.3M | SAR 35.2B | SAR 318.16 | 1.04% down | 16% up | ||
| 146 | Universal Health ServicesUHS · Health Care | SAR 517M | SAR 37.8B | SAR 656.51 | 5.96% down | 25% down | ||
| 147 | Halozyme TherapeuticsHALO · Health Care | SAR 502.1M | SAR 39.8B | SAR 349.08 | 2.88% down | 32% up | ||
| 148 | Protagonist TherapeuticsPTGX · Health Care | SAR 481.7M | SAR 30.4B | SAR 465.31 | 2.47% down | 51% up | ||
| 149 | CytokineticsCYTK · Health Care | SAR 459.7M | SAR 26.9B | SAR 193.07 | 0.27% up | 19% down | ||
| 150 | Corcept TherapeuticsCORT · Health Care | SAR 452.1M | SAR 26.7B | SAR 243.80 | 4.15% down | 16% down | ||
| 151 | Cooper CompaniesCOO · Health Care | SAR 415M | SAR 43B | SAR 226.35 | 0.69% down | 15% down | ||
| 152 | Travere TherapeuticsTVTX · Health Care | SAR 349.1M | SAR 17.4B | SAR 181.22 | 3.86% down | 45% up | ||
| 153 | GlaukosGKOS · Health Care | SAR 340.7M | SAR 52.9B | SAR 893.33 | 2.15% up | 139% up | ||
| 154 | BrightSpring Health ServicesBTSG · Health Care | SAR 331.6M | SAR 47.8B | SAR 240.20 | 6.32% down | 85% up | ||
| 155 | ImmunityBioIBRX · Health Care | SAR 331.4M | SAR 26.2B | SAR 24.65 | 1.94% down | 216% up | ||
| 156 | Spyre TherapeuticsSYRE · Health Care | SAR 321.6M | SAR 34.8B | SAR 366.30 | 3.77% down | 332% up | ||
| 157 | Concentra Group Holdings ParentCON · Health Care | SAR 299.8M | SAR 19.6B | SAR 155.52 | 1.12% down | 116% up | ||
| 158 | TG TherapeuticsTGTX · Health Care | SAR 297M | SAR 36.8B | SAR 243.42 | 1.88% down | 103% up | ||
| 159 | ChemedCHE · Health Care | SAR 279.6M | SAR 26.8B | SAR 2,068.54 | 0.84% up | 27% up | ||
| 160 | ErascaERAS · Health Care | SAR 276.9M | SAR 18.7B | SAR 53.35 | 3.34% up | 387% up | ||
| 161 | Encompass HealthEHC · Health Care | SAR 270.9M | SAR 48.7B | SAR 496.30 | 1.96% down | 20% up | ||
| 162 | Adaptive BiotechnologiesADPT · Health Care | SAR 264.5M | SAR 17B | SAR 105.24 | 1.44% down | 74% up | ||
| 163 | Mettler-Toledo InternationalMTD · Health Care | SAR 251M | SAR 127.3B | SAR 6,399.47 | 1.82% down | 17% up | ||
| 164 | Edgewise TherapeuticsEWTX · Health Care | SAR 229.4M | SAR 16.9B | SAR 154.47 | 0.48% down | 82% up | ||
| 165 | Rhythm PharmaceuticalsRYTM · Health Care | SAR 203.7M | SAR 30.4B | SAR 438.22 | 1.88% down | 15% up | ||
| 166 | Dianthus TherapeuticsDNTH · Health Care | SAR 191.7M | SAR 17.9B | SAR 318.27 | 1.01% up | 105% up | ||
| 167 | Oruka TherapeuticsORKA · Health Care | SAR 176.1M | SAR 24.8B | SAR 366.07 | 1.91% up | 255% up | ||
| 168 | HeartflowHTFL · Health Care | SAR 168M | SAR 14.7B | SAR 167.45 | 2.75% down | 66% up | ||
| 169 | CG OncologyCGON · Health Care | SAR 121.9M | SAR 27.4B | SAR 307.28 | 2.38% up | 93% up | ||
| 170 | VeradermicsMANE · Health Care | SAR 81.7M | SAR 19.7B | SAR 466.70 | 0.38% down | 230% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Cash on hand is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 3.7519 SAR).
Questions and answers
Which health care companies rank first by cash on hand?
UnitedHealth Group (SAR 91.4B), Johnson & Johnson (SAR 73.9B) and Centene (SAR 67.1B) are the top three of the 170 health care companies ranked by cash on hand as of 20 Nov 2026, 11:43 UTC.
How many health care companies are in this ranking?
170 are ranked by cash on hand.
What are these health care companies worth together?
The 170 health care companies ranked by cash on hand have a combined market value of SAR 33.47T as of 20 Nov 2026, 11:43 UTC.
What does ranking by cash on hand measure?
Cash and cash equivalents at the end of the latest fiscal year. Short-term investments are not counted.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest health care companies by cash on hand”, data as of 20 November 2026. https://funkfolio.com/companies/sector/health-care?by=cash-on-hand
Underlying data: Yahoo Finance; SEC EDGAR.